Aktie 8432 TSH BIOPHARM CORPORATION LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen TSH Biopharm Corporation Limited

Aktien

8432

TW0008432006

8432

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 10.05.2024 		% 5 Tage % 1. Jan.
66 TWD -1,64 % Intraday Chart für TSH Biopharm Corporation Limited +10,92 % +31,21 %
07.05. TSH Biopharm Corporation Limited meldet die Ergebnisse für das erste Quartal bis zum 31. März 2024 CI
11.03. TSH Biopharm Corporation Limited kündigt Änderungen im Direktorium zum 1. April 2024 an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024
TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024
TSH Biopharm Corporation Limited agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million.
TSH Biopharm Corporation Limited agreed to acquire 51% stake in TOP Biological Technology Company Limited from Shen Feng Co., Ltd., Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd. ANIMATO INTERNATIONAL COMPANY and others for TWD 44.3 million.
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023
TSH Biopharm Corporation Limited Announces the Change of Financial Officer, Effective on January 1, 2024
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tsh Biopharm Corporation Limited Announces the Change of Audit Committee Members
Tsh Biopharm Corporation Limited Announces Dividend for the Year 2022, Payable on July 14, 2023
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
TSH Biopharm : is invited to attend the online institutional investor conference hosted by IBF Securities
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022
TSH Biopharm : Announcement of setting up the Sustainable Development Committee and members of TSH's first Sustainable Development Committee
TSH Biopharm Corporation Limited Announces Board Appointments
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 8432 Aktie
  4. Nachrichten TSH Biopharm Corporation Limited
  5. Andere Sprachen